|
[1] Ulf Madsen, Krogsgaard-Larsen Povl, Tommy Liljefors (2002). Textbook of drug design and discovery. Washington, DC: Taylor & Francis. ISBN 0-415-28288-8. [2] Hann MM, Oprea TI (June 2004). "Pursuing the leadlikeness concept in pharmaceutical research". Curr Opin Chem Biol. 8 : 255–63. [3] Walters WP, Stahl MT, Murcko MA (1998). "Virtual screening – an overview". Drug Discov. Today. 3 : 160–178. [4] Kitchen DB, Decornez H, Furr JR, Bajorath J (2004). "Docking and scoring in virtual screening for drug discovery: methods and applications". Nature reviews. Drug discovery. 3 : 935–49. [5] 石方牛 (2007). “TY-WQ抗抑鬱作用的物質基礎及機理的探索研究“. 天津醫科大學碩士畢業論文 [6] Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM Jr, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA (1995). "A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules". J. Am. Chem. Soc. 117: 5179–5197. [7] Biedenharn LC, Louck JD (1981). Angular Momentum in Quantum Physics, Reading, MA: Addison-Wesley, ISBN 978-0-201-13507-7
|